...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Pfizer

I think one of the really good things about Zenith Cap Corp is that Hepalink does not have a substantial interest.I know other Chinese investors have some but the control is in Western hands.The Chinese situation is not looking good at present.Would like an update on the Breast cancer trial DM was positive a few months ago.

Share
New Message
Please login to post a reply